We searched PubMed from Jan 1, 1990, to March 31, 2013, with the terms “point-of-care”, “diagnostic tests”, and “resource-limited settings” for all available articles. We selected case reports, case series, epidemiological studies, and reviews of human diseases published in English. We also reviewed references from selected publications.
ReviewDiagnostic point-of-care tests in resource-limited settings
Introduction
Diagnostic technologies have improved substantially over the past few decades.1 In developed countries, laboratory testing has become increasingly automated, which improves reliability and reduces operator time. Diagnostic testing is now a fundamental part of medical practice, especially in the present era of drug-resistant infectious diseases. As turnaround times for laboratory tests shorten, and as laboratory results become increasingly integrated with electronic medical records, clinicians can receive test results even faster, which should improve care of patients and outcomes.2
Despite these advances, most advanced diagnostic laboratory technologies are centralised, and need highly trained staff and specialised facilities. The equipment is generally expensive and needs regular maintenance by skilled technicians. Consequently, many laboratory-based tests regarded as standard in developed countries are cost prohibitive and inaccessible to most patients and clinicians in many other countries.3, 4 In recognition of this disparity, WHO and others have called for new clinical diagnostic methods that can function in settings with restricted access to a central laboratory.5, 6, 7, 8, 9 By some estimates, the deployment of rapid, laboratory-independent diagnostic tests for just four infections (bacterial pneumonia, syphilis, malaria, and tuberculosis) could prevent more than 1·2 million deaths each year in developing countries.10, 11, 12
Diagnostic testing done at or near the site of care, called point-of-care testing, can provide results to a clinician without having to wait days or even hours for sample transport and laboratory processing.13 The point-of-care testing era began in 1962, when a new, rapid method to measure blood glucose concentrations14 was developed, and was bolstered in 1977, with the introduction of a rapid pregnancy test.15 Point-of-care testing in clinics and hospitals gained substantial traction in the early 1990s with the introduction of small, portable devices that could measure several electrolytes in emergency departments.16, 17 In the two decades since, many point-of-care tests have been developed. These tests now exist for many diseases and medical specialties, and are used in most medical contexts, from general outpatient clinics to intensive care units (panel 1).54, 55 In 2012, nearly 100 companies worldwide were marketing, manufacturing, or developing test instruments or reagents for use at the clinical point-of-care,56 suggesting that point-of-care testing, including novel nucleic-acid-based point-of-care tests, will become even more widely used.57, 58
The emergence of point-of-care tests has the potential to improve health-care services and patient-centred outcomes in diverse settings, especially those with poor health service or laboratory infrastructure.4, 59 Access to improved diagnostic technologies in resource-limited settings will bring unique challenges.60 The development and design of user-friendly devices, regulatory approval, and quality assurance programmes, and product service and support, all need to be addressed in novel ways.4, 58, 61, 62, 63, 64, 65, 66, 67 Moreover, to make prudent decisions about the introduction of new diagnostic technologies in resource-limited settings, decision makers need well executed studies on diagnostic accuracy, clinical effect, and cost.
We searched for and assessed reports containing definitions of point-of-care testing and studies of point-of-care tests in resource-limited settings. We found no consistent, formalised approach to assess point-of-care technologies in these settings. On the basis of this review, we provide a novel framework to assess diagnostic point-of-care tests in resource-limited settings to encourage standardised reporting of performance and effect, which should enable more direct and accurate comparisons between point-of-care technologies and their central laboratory-based counterparts.
Section snippets
Definition of point-of-care diagnostic tests
Several definitions of point-of-care test exist based on geographical, functional, technological, or operational contexts.68 An early definition was “a medical test that is conducted at or near the site of patient care”.13 Years later, another definition was “any test that is performed at the time at which the test result enables a clinical decision to be made and an action taken that leads to an improved health outcome”.69 More recently, experts on HIV and tuberculosis diagnostic testing
Studies of point-of-care tests in resource-limited settings
Many point-of-care tests have been designed for use in developed countries, and might not be readily transferable to resource-limited settings.4 When point-of-care tests are used in resource-replete emergency departments or intensive care units, the goal of point-of-care testing is to obtain immediate test results to help guide an emergent intervention. In resource-limited settings, where limited access to care is one of the major reasons for the failure of health services,73 point-of-care
Accuracy
As point-of-care testing expands into resource-limited settings, appropriate assessments of accuracy are essential. A fundamental criterion for success of any diagnostic point-of-care test is its accuracy and reliability.95 Studies of test performance might include sensitivity and specificity, positive and negative likelihood ratios, and positive and negative predictive values. These studies are usually the first and most common to appear in the scientific publications, and they estimate the
Discussion
The popularity and potential applications of diagnostic point-of-care testing in resource-limited settings have been growing and will probably expand. The aim of point-of-care testing is to provide a fast test result to clinicians and patients so that they might make an expedited clinical management decision, to improve outcomes for patients and overall public health.54 Improved outcomes can still be achieved at the expense of decreased test performance, if, for example, point-of-care tests
Search strategy and selection criteria
References (147)
- et al.
Point-of-care tests for diagnosing infections in the developing world
Clin Microbiol Infect
(2010) - et al.
Point-of-care testing and cardiac biomarkers: the standard of care and vision for chest pain centers
Cardiol Clin
(2005) - et al.
Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care
Rev Esp Cardiol
(2012) - et al.
Point-of-care genetic testing for personalization of antiplatelet treatment (RAPID GENE): a prospective, randomized, proof-of-concept trial
Lancet Infect Dis
(2012) - et al.
Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study
Lancet
(2011) - et al.
Tetanus Quick Stick as an applicable and cost-effective test in assessment of immunity status
Am J Emerg Med
(2011) - et al.
Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study
Lancet Infect Dis
(2012) - et al.
Diagnostics tests for Kala-Azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KA-tex in East Africa and the Indian sub-continent
Trans R Soc Trop Med Hyg
(2008) Point of care testing
Clin Lab Med
(2007)- et al.
Point-of-care nucleic acid testing for infectious diseases
Trends Biotechnol
(2011)
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
Lancet
Emerging technologies for point-of-care CD4 T-lymphocyte counting
Trends Biotechnol
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study
Lancet
Refining clinical diagnosis with likelihood ratios
Lancet
Microfluidics-based diagnostics of infectious diseases in the developing world
Nat Med
Potential of rapid diagnosis for controlling drug-susceptible and drug-resistant tuberculosis in communities where Mycobacterium tuberculosis infections are highly prevalent
J Clin Microbiol
Diagnostics for the developing world
Nat Rev Microbiol
Rapid and simple point-of-care diagnostics for STIs
Sex Transm Infect
Diagnostics for tuberculosis: global demand and market potential. Geneva
Requirements for high impact diagnostics in the developing world
Nature
Global health diagnostics
Nature
Global infectious disease surveillance and detection: assessing the challenges – finding solutions, workshop summary
Reducing the global burden of tuberculosis: the contribution of improved diagnostics
Nature
Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics
Nature
Estimating the global health impact of improved diagnostic tools for the developing world. Research highlights
Principles and practice of point-of-care testing
Electrode systems for continuous monitoring in cardiovascular surgery
Ann N Y Acad Sci
A timeline of pregnancy testing
The evaluation of a portable clinical analyzer in the emergency department
Am J Clin Pathol
Evaluation of a novel point-of-care system, the i-STAT portable clinical analyzer
Clin Chem
PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay
Clin Chem Lab Med
How accurately does the Reflotron dry-chemistry system measure plasma total cholesterol levels when used as a community-screening device
Med J Aust
Evaluating the QuikRead C-reactive protein test as a point-of-care test
Paediatr Int Child Health
C-reactive protein point-of-care testing for lower respiratory tract infections: a qualitative evaluation of experiences by GPs
Fam Pract
Evaluating the validity of a bedside method of detecting hypoglycemia in children
Pediatr Emerg Care
Comparison of point of care and laboratory HbA1c analysis: a MetroNet study
J Am Board Fam Med
Accuracy and precision of the axis-shield afinion hemoglobin A1c measurement device
J Diabetes Sci Technol
A paper-based multiplexed transaminase test for low-cost, point-of-care liver function testing
Sci Trans Med
Comparison and evaluation of a point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin
Thromb Res
Providing immediate CD4 count results at HIV testing improves ART initiation
J Acquir Immun Defic Syndr
Performance of a rapid, on-site human immunodeficiency virus antibody assay in a public health setting
J Clin Microbiol
Diagnosing human African trypanosomiasis in Angola using a care agglutination test: observational study of active and passive case finding strategies
BMJ
Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men
Health Technol Assess
Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis
Clin Infect Dis
Evaluation of rapid antigen point-of-care tests for detection of giardia and cryptosporidium species in human fecal specimens
J Clin Microbiol
Utility of a point-of-care malaria rapid diagnostic test for excluding malaria as the cause of fever among HIV-positive adults in rural Rakai, Uganda
Am J Trop Med Hyg
The role of point of care testing for patients with acute pharyngitis
J Gen Intern Med
Accuracy of rapid and point-of-care screening tests for hepatitis C: a systematic review and meta-analysis
Ann Intern Med
A five-country evaluation of a point-of-care circulating cathodic antigen urine assay for the prevalence of Schistosoma mansoni
Am J Trop Med
Cited by (500)
A novel fluorescent biosensor for sensitive detection of pathogenic bacteria based on catalytic hairpin assembly and λ-Exonuclease cleavage reaction
2024, Sensors and Actuators B: ChemicalMOF-functionalized paper-based biosensors: Fabrications, mechanisms and applications
2024, TrAC - Trends in Analytical ChemistryRecent advances in molecularly imprinted polymer-based electrochemical sensors
2024, Biosensors and BioelectronicsAn evaluation of the commonly used portable medical sensors performance in comparison to clinical test results for telehealth systems
2024, Computer Methods and Programs in Biomedicine UpdateElectroanalytical paper-based device for reliable detection and quantification of sugars in milk
2024, Sensors and Actuators B: Chemical